Accuray Incorporated (ARAY) : Oracle Investment Management Inc reduced its stake in Accuray Incorporated by 11.48% during the most recent quarter end. The investment management company now holds a total of 2,553,218 shares of Accuray Incorporated which is valued at $13,915,038 after selling 331,087 shares in Accuray Incorporated , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Accuray Incorporated makes up approximately 2.54% of Oracle Investment Management Inc’s portfolio.
Other Hedge Funds, Including , Partner Fund Management boosted its stake in ARAY in the latest quarter, The investment management firm added 760,070 additional shares and now holds a total of 5,884,218 shares of Accuray Incorporated which is valued at $32,068,988. Accuray Incorporated makes up approx 1.09% of Partner Fund Management’s portfolio.Renaissance Technologies boosted its stake in ARAY in the latest quarter, The investment management firm added 537,600 additional shares and now holds a total of 3,319,000 shares of Accuray Incorporated which is valued at $18,088,550. Accuray Incorporated makes up approx 0.03% of Renaissance Technologies’s portfolio.Blackrock Group Ltd reduced its stake in ARAY by selling 619 shares or 1.68% in the most recent quarter. The Hedge Fund company now holds 36,117 shares of ARAY which is valued at $196,838.Advisory Services Network boosted its stake in ARAY in the latest quarter, The investment management firm added 3,500 additional shares and now holds a total of 21,900 shares of Accuray Incorporated which is valued at $119,574. Accuray Incorporated makes up approx 0.03% of Advisory Services Network’s portfolio.
Accuray Incorporated closed down -0.03 points or -0.56% at $5.3 with 5,84,890 shares getting traded on Thursday. Post opening the session at $5.31, the shares hit an intraday low of $5.2539 and an intraday high of $5.36 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.
On the company’s financial health, Accuray Incorporated reported $-0.09 EPS for the quarter, missing the analyst consensus estimate by $ -0.02 based on the information available during the earnings call on Aug 17, 2016. Analyst had a consensus of $-0.07. The company had revenue of $95.00 million for the quarter, compared to analysts expectations of $99.46 million. The company’s revenue was down -6.7 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.07 EPS.
Accuray Incorporated is a radiation oncology company. The Company develops manufactures sells and supports treatment solutions. Its suite of products includes the CyberKnife Systems and the TomoTherapy Systems. Its technologies the CyberKnife and TomoTherapy Systems are designed to deliver treatments including radiosurgery stereotactic body radiation therapy intensity modulated radiation therapy image guided radiation therapy and adaptive radiation therapy. Its principal radiosurgery products the CyberKnife Systems are robotic full-body radiosurgery system designed to treat tumors anywhere in the body non-invasively which include the CyberKnife M6 Series with configuration options of fixed collimators plus iris variable aperture collimator fixed collimators plus the InCise MLC and fixed collimators plus iris variable aperture collimator and the InCise MLC. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH TomoHD and TomoHDA.